In a tissue microarray of prostate cancer patients, decreased levels of lamin A/C and B2 were found to correlate with increased risk of lymph node metastasis and disease-specific death, while increased levels of lamin B1 were associated with disease recurrence [19]. This evidence concerns the gene LMNB1 and metastatic malignant neoplasm in the lymph nodes.